Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
nan%
ALSO IN MEDX
MEDX
27
HOLDINGS
0%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
IXJ Overweight Relative to MEDX
| PACIFIC BIOSCIENCES OF CALIF | -0.1% | |
| ALLOGENE THERAPEUTICS, INC. | -0.1% | |
| VIATRIS, INC. | -0.2% | |
| EDITAS MEDICINE, INC. | -0.3% | |
| GE HEALTHCARE TECHNOLOGIES INC. | -0.4% | |
| LANTERN PHARMA, INC. | -0.4% | |
| INTELLIA THERAPEUTICS, INC. | -0.7% | |
| REPLIMUNE GROUP, INC. | -0.7% | |
| GALECTIN THERAPEUTICS INC | -1.1% | |
| VANDA PHARMACEUTICALS INC | -1.2% |
IXJ Underweight Relative to MEDX
| ELI LILLY & CO | -18.3% | |
| ABBVIE INC | -8.9% | |
| NOVARTIS AG-ADR | -6.7% | |
| ASTRAZENECA PLC-SPONS ADR | -5.3% | |
| JOHNSON & JOHNSON | -5.0% | |
| IONIS PHARMACEUTICALS, INC. | -5.0% | |
| ALNYLAM PHARMACEUTICALS INC | -5.0% | |
| BRISTOL-MYERS SQUIBB CO | -4.6% | |
| AMGEN INC | -3.9% | |
| MERCK & CO. INC. | -3.6% |